Clinical Trial Software for Oncology Research
Manage complex multi-arm oncology trials with adaptive designs, biomarker tracking, and real-time safety monitoring — all in one unified platform.
Clincove provides purpose-built clinical trial management software for oncology research. Our platform supports Phase I-IV oncology trials with native adaptive design capabilities, integrated biomarker tracking, automated safety surveillance, and multi-site coordination across global regulatory jurisdictions.
Challenges in Oncology Trials
These are the problems that slow down oncology research. Clincove was designed to solve them.
Complex Protocol Designs
Oncology trials often involve adaptive designs, dose escalation, and multiple treatment arms that overwhelm traditional EDC systems. Protocol amendments are frequent, and each change can require weeks of costly rebuilds across interconnected forms and workflows.
Biomarker & Companion Diagnostics
Coordinating biomarker data with clinical endpoints requires seamless data integration across labs and sites. Central and local lab results need to flow into the EDC in real time for stratification decisions and endpoint analysis.
Safety Monitoring at Scale
Real-time SAE tracking and DSMB reporting are critical when patients face serious adverse events. Legacy systems often introduce delays between signal detection and committee notification, putting patient safety at risk.
Multi-site Complexity
Global oncology trials span dozens of sites across regulatory jurisdictions with varying requirements. Coordinating site training, data standards, and regulatory submissions across regions introduces significant operational overhead.
How Clincove Solves It
Purpose-built features that address the specific needs of oncology clinical trials.
Adaptive Trial Support
Built-in support for adaptive designs, dose escalation schemas, and protocol amendments without costly EDC rebuilds. Changes propagate automatically across all forms, visits, and sites — reducing amendment implementation from weeks to days.
Integrated Biomarker Tracking
Native integration between lab data, eSource, and EDC for real-time biomarker-endpoint correlation. Central lab results flow directly into patient records with automated flagging for stratification and eligibility checks.
Real-time Safety Dashboard
Automated SAE workflows with instant DSMB reporting and real-time safety signal detection across all sites. Configurable alert thresholds notify safety teams immediately when concerning patterns emerge in the data.
Global Regulatory Compliance
Pre-built compliance with FDA, EMA, PMDA, and NMPA requirements for oncology submissions. Region-specific regulatory packages ensure each site meets local requirements while maintaining global data consistency.
Results That Matter
Measurable impact for oncology trial teams using Clincove.
The Clincove Platform for Oncology
Every module works together seamlessly to power your oncology trials from protocol to submission.
Related Therapeutic Areas
Explore how Clincove supports trials across other therapeutic areas.
Frequently Asked Questions
Common questions about oncology clinical trial software.
Clincove provides native support for adaptive designs, dose escalation schemas, and integrated biomarker tracking — capabilities that typically require expensive custom builds on legacy EDC platforms. Our platform handles protocol amendments in days instead of weeks and includes real-time safety dashboards purpose-built for oncology risk profiles.
Yes. Clincove supports complex multi-arm, multi-stage (MAMS) designs, basket trials, umbrella trials, and platform trials out of the box. Treatment arms can be added, modified, or dropped mid-study without rebuilding the entire EDC configuration.
Clincove connects directly to central labs and provides a unified view of biomarker data alongside clinical endpoints. Lab results flow into the EDC in real time for automated stratification, eligibility screening, and biomarker-endpoint correlation analysis.